http://rdf.ncbi.nlm.nih.gov/pubchem/patent/BR-112022010907-A2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c727d0aef5b1f28290f7ccdf941d6ead
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2300-00
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-07
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2896
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-39541
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5355
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-573
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-57
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-08
filingDate 2020-12-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_db99eed9f9b24b7644e567b3e008592c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c8cf92137d9c9024fdc7569a7900cddf
publicationDate 2022-10-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber BR-112022010907-A2
titleOfInvention USE OF ISATUXIMAB FOR THE TREATMENT OF RECURRING AND/OR REFRACTORY MULTIPLE MYELOMA
abstract USE OF ISATUXIMAB FOR THE TREATMENT OF RECURRING AND/OR REFRACTORY MULTIPLE MYELOMA. The present invention relates to methods of treating multiple myeloma (such as refractory multiple myeloma or relapsed and refractory multiple myeloma) in a subject who has received one to three prior therapies (or prior lines of therapy) for multiple myeloma. The methods comprise administering to the subject an anti-CD38 antibody, carfilzomib and dexamethasone.
priorityDate 2019-12-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11556711
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5743
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419492800
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419497453

Total number of triples: 29.